GoHealth, Inc. 8-K

What Happened

• GoHealth, Inc. (GOCO) and related entities filed voluntary Chapter 11 petitions on June 7, 2026, to implement a prepackaged plan of reorganization.
• On June 9, 2026, Nasdaq’s Listing Qualifications Staff notified GoHealth that it has determined to delist the Company’s Class A common stock under Nasdaq rules; trading is scheduled to be suspended at the opening of business on June 16, 2026.
• The company says it does not intend to appeal Nasdaq’s delisting determination and plans the Form 25-NSE to remove the stock from Nasdaq registration.

Key Details

• Chapter 11 petitions filed: June 7, 2026; Nasdaq delisting notice dated June 9, 2026; trading suspension effective June 16, 2026.
• Nasdaq cited (i) the Chapter 11 filing and related public interest concerns, (ii) concerns about residual equity for existing holders, and (iii) ability to meet continued listing requirements.
• Nasdaq also noted prior noncompliance (notice on March 18, 2026) with Listing Rule 5550(b)(2), which requires a minimum market value of listed securities of $35 million.
• GoHealth expects its Class A common stock may trade on the OTC Markets (e.g., OTCID Basic Market) after suspension but warned liquidity and quotes could be limited.

Why It Matters

• Delisting and suspension will likely reduce liquidity and make it harder for current and potential investors to buy or sell GOCO shares; over-the-counter trading typically has less transparency and volume than Nasdaq.
• The Chapter 11 process could materially affect equity holders: the disclosed Plan may cancel existing equity interests (other than Series A redeemable convertible preferred stock), with limited recovery expected for holders of Class A common stock.
• The company cautioned trading during the Chapter 11 Cases is highly speculative and that market prices may not reflect any ultimate recovery; the outcome depends on confirmation and consummation of the Plan and Bankruptcy Court proceedings.